Treating Cervical Dysplasia: Why Does It Matter?

References

1. ↵
   Mulhem E, Kennedy EL, Lick D. Treatment of cervical dysplasia with the Fischer cone biopsy excisor in a family medicine office: a case series. J Am Board Fam Med 2010; 23: 154–8.

   OpenUrlAbstract/FREE Full Text
2. ↵
   Grumbach K. Redesign of the health care delivery system: a Bauhaus “form follows function” approach. JAMA 2009; 302: 2363–4.

   OpenUrlCrossRefPubMed
3. Starfield B. Family medicine should shape reform, not vice versa. Fam Pract Manag 2009; 16: 6–7.

   OpenUrlPubMed
4. Evans TE, Palmer E, Abercrombie S, et al. Advocacy: the time is now. Ann Fam Med 2009; 7: 376–7.

   OpenUrlFREE Full Text
5. Rosenthal TC. The medical home: growing evidence to support a new approach to primary care. J Am Board Fam Med 2008; 21: 427–40.

   OpenUrlAbstract/FREE Full Text
6. ↵
   Khanna N, Nesbitt L, Roghmann MC, Tacket C. Translation of clinical research into practice: defining the clinician scientist. Fam Med 2009; 41: 440–3.

   OpenUrlPubMed
7. ↵
   American Cancer Society. What are the key statistics about cervical cancer? Available at http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_are_the_key_statistics_for_cervical_cancer_8.asp?sitearea=. Accessed 27 December 2009.
8. ↵
   Insinga RP, Glass AG, Rush BB. Diagnoses and outcomes in cervical cancer screening: a population-based study. Am J Obstet Gynecol 2004; 191: 105–13.

   OpenUrlCrossRefPubMedWeb of Science
9. ↵
   Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 2007; 45: 107–14. Epub 2007 Jun 2.

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 ASCCP-Sponsored Consensus Conference. 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis. 2007; 11: 201–22. Erratum in J Low Genit Tract Dis 2008;12:255.

    OpenUrlCrossRefPubMed
11. ↵
    Khanna N, Dalby R, Tan M, Arnold S, Stern J, Frazer N. Phase I/II clinical safety studies of terameprocol vaginal ointment. Gynecol Oncol 2007; 107: 554–62.

    OpenUrlCrossRefPubMed
12. ↵
    Massad LS, Jeronimo J, Schiffman M, National Institutes of Health/American Society for Colposcopy and Cervical Pathology (NIH/ASCCP) Research Group. Interobserver agreement in the assessment of components of colposcopic grading. Obstet Gynecol 2008; 111: 1279–84.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    Wentzensen N, Schiffman M, Dunn ST, et al. Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1,700 women referred to colposcopy in Oklahoma. Int J Cancer 2009; 124: 964–9.

    OpenUrlCrossRefPubMed
14. ↵
    Solomon D, Stoler M, Jeronimo J, Khan M, Castle P, Schiffman M. Diagnostic utility of endocervical curettage in women undergoing colposcopy for equivocal or low-grade cytologic abnormalities. Obstet Gynecol 2007; 110(2 Pt 1): 288–95.

    OpenUrlCrossRefPubMedWeb of Science
15. ↵
    Apple Medical Corporation. Fischer cone biopsy excisor. Available at http://www.applemed.com/product.php?product=fischer_cone_biopsy_excisor. Accessed 27 December 2009.